Fuqiang Dai

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Epidermal Growth Factor Receptor

Ejection Fraction

Top Venues

Thoracic cancer

Current oncology (Toronto, Ont.)

This page only lists publications with an associated author ORCID identifier.

Publications

Fuqiang Dai, Cong Chen, Guanyu Zhou, Xintian Wang, Longyong Mei, Nanzhi Luo, Wenjing Zhou, Tao Li, Deng Bo, Lun-Xu Liu, Yun Wang
Subsequent surgical treatment or maintenance immunotherapy in stage III lung cancer patients achieving a favorable response following neoadjuvant immunotherapy: A matched retrospective cohort study from the surgical perspective. Thoracic cancer (2024)
Fuqiang Dai, Cong Chen, Guanyu Zhou, Xintian Wang, Longyong Mei, Nanzhi Luo, Wenjing Zhou, Tao Li, Deng Bo, Lun-Xu Liu, Yun Wang
Subsequent surgical treatment or maintenance immunotherapy in stage III lung cancer patients achieving a favorable response following neoadjuvant immunotherapy: A matched retrospective cohort study from the surgical perspective. Thoracic cancer 15 (10) (2024)
Fuqiang Dai, Cong Chen, Guanyu Zhou, Xintian Wang, Longyong Mei, Nanzhi Luo, Wenjing Zhou, Tao Li, Deng Bo, Lun-Xu Liu, Yun Wang
Subsequent surgical treatment or maintenance immunotherapy in stage III lung cancer patients achieving a favorable response following neoadjuvant immunotherapy: A matched retrospective cohort study from the surgical perspective. Thoracic cancer 15 (10) (2024)
Fuqiang Dai, Cong Chen, Guanyu Zhou, Xintian Wang, Longyong Mei, Nanzhi Luo, Wenjing Zhou, Tao Li, Deng Bo, Lun-Xu Liu, Yun Wang
Subsequent surgical treatment or maintenance immunotherapy in stage III lung cancer patients achieving a favorable response following neoadjuvant immunotherapy: A matched retrospective cohort study from the surgical perspective. Thoracic cancer 15 (10) (2024)
Fuqiang Dai, Cong Chen, Guanyu Zhou, Xintian Wang, Longyong Mei, Nanzhi Luo, Wenjing Zhou, Tao Li, Deng Bo, Lun-Xu Liu, Yun Wang
Subsequent surgical treatment or maintenance immunotherapy in stage III lung cancer patients achieving a favorable response following neoadjuvant immunotherapy: A matched retrospective cohort study from the surgical perspective. Thoracic cancer 15 (10) (2024)
Xiaoli Wu, Hanyang Xing, Ping Chen, Jihua Ma, Xintian Wang, Chengyi Mao, Xiaoying Zhao, Fuqiang Dai
Lymph Node Dissection Is a Risk Factor for Short-Term Cough after Pulmonary Resection. Current oncology (Toronto, Ont.) 29 (1) (2022)